Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- HZNP -30.4%, OMED -13.3%, CIE -11.6%, AU -3.5%, TSN -2.1%,HRG -1.9%, TAC -0.9%
M&A news:
- DGII -1.1% (Belden (BDC) rescinds proposal to acquire 100% of Digi in light of the fiscal second quarter 2017 results and full-year 2017 outlook reported by Digi on May 4)
Select EU financial related names showing weakness:
- CS -6.8%, BBVA -3.4%, SAN -3.4%, DB -2.6%, ING -2.2%, LYG -1.6%
Select metal producers trading lower:
- MT -3.2%, BBL -2.2%, BHP -2%, RIO -1.9%, FCX -1.8%, CLF -1.4%
Other news:
- OMED -13.3% (Phase 2 Demcizumab DENALI non-small cell lung cancer trial did not meet endpoints)
- TXMD -10.1% (receives a CRL from the FDA regarding the NDA for TX-004HR)
- SNGX -7.2% (files for $25 mln mixed securities shelf offering)
- MLCO -4.6% (announces the launch of a public offering of 27,769,248 )
- FNCX -4.2% (enters into binding agreements for the sale of $10 mln of its Series G Convertible Preferred Stock)
- WYNN -2.1% (Reuters details that Macau plans to monitor ATM withdrawals)
- LVS -2% (Reuters details that Macau plans to monitor ATM withdrawals)
- AUO -1.5% (reports Apr sales)
Analyst comments:
- MU -2.3% (downgraded to Neutral from Buy at Goldman)
- LYB -1% (downgraded to Underperform at BofA/Merrill)